PT  - JOURNAL ARTICLE
AU  - Prajakta Shende
AU  - Pradip Gaikwad
AU  - Manisha Gandhewar
AU  - Pawankumar Ukey
AU  - Anshul Bhide
AU  - Vainav Patel
AU  - Sharad Bhagat
AU  - Vikrant Bhor
AU  - Smita Mahale
AU  - Rahul Gajbhiye
AU  - Deepak Modi
TI  - Persistence of SARS-CoV-2 in the first trimester placenta leading to vertical transmission and fetal demise from an asymptomatic mother
AID  - 10.1101/2020.08.18.20177121
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.18.20177121
4099  - http://medrxiv.org/content/early/2020/08/21/2020.08.18.20177121.short
4100  - http://medrxiv.org/content/early/2020/08/21/2020.08.18.20177121.full
AB  - Coronaviruses infect the respiratory tract and are known to survive in these tissues during the clinical course of infection. However, how long can SARS-CoV-2 survive in the tissues is hitherto unknown. Herein, we report a case where the virus is detected in the first trimester placental cytotrophoblast and syncytiotrophoblasts five weeks after the asymptomatic mother cleared the virus from the respiratory tract. This first trimester placental infection was vertically transmitted as the virus was detected in the amniotic fluid and fetal membranes. This congenitally acquired SARS-CoV-2 infection was associated with hydrops and fetal demise. This is the first study providing concrete evidences towards persistent tissue infection of SARS-CoV-2, its congenital transmission in early pregnancy leading to intrauterine fetal death.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study is a case report and not a clinical trialFunding StatementNo specific funding was received fro this manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute Ethics committee of ESI- PGIMSR and Model Hospital, Mumbai from where the case is reportedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is available from the authors upon request